Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act

Saved in:
Bibliographic Details
Main Authors: Mohammed Essa, Joseph S. Ross, Sanket S. Dhruva, Nihar R. Desai, Erica S. Spatz, Kamil F. Faridi
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.034682
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540942464188416
author Mohammed Essa
Joseph S. Ross
Sanket S. Dhruva
Nihar R. Desai
Erica S. Spatz
Kamil F. Faridi
author_facet Mohammed Essa
Joseph S. Ross
Sanket S. Dhruva
Nihar R. Desai
Erica S. Spatz
Kamil F. Faridi
author_sort Mohammed Essa
collection DOAJ
format Article
id doaj-art-1a85dff54c6343be903d813ff37ab802
institution Kabale University
issn 2047-9980
language English
publishDate 2025-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-1a85dff54c6343be903d813ff37ab8022025-02-04T11:00:01ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802025-02-0114310.1161/JAHA.124.034682Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction ActMohammed Essa0Joseph S. Ross1Sanket S. Dhruva2Nihar R. Desai3Erica S. Spatz4Kamil F. Faridi5New England Heart and Vascular Institute Catholic Medical Center Manchester NH USASection of General Internal Medicine, Department of Medicine, Yale School of Medicine, Department of Health Policy and Management Yale School of Public Health New Haven CT USASection of Cardiology, Department of Medicine University of California at San Francisco School of Medicine San Francisco CA USACenter for Outcomes Research and Evaluation Yale New Haven Health System New Haven CT USACenter for Outcomes Research and Evaluation Yale New Haven Health System New Haven CT USACenter for Outcomes Research and Evaluation Yale New Haven Health System New Haven CT USAhttps://www.ahajournals.org/doi/10.1161/JAHA.124.034682cardiovascular diseasesdrug costsMedicaidMedicare Part Dprescription drugs
spellingShingle Mohammed Essa
Joseph S. Ross
Sanket S. Dhruva
Nihar R. Desai
Erica S. Spatz
Kamil F. Faridi
Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cardiovascular diseases
drug costs
Medicaid
Medicare Part D
prescription drugs
title Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act
title_full Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act
title_fullStr Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act
title_full_unstemmed Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act
title_short Ten‐Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act
title_sort ten year medicare use and spending on the 10 drugs selected for negotiation under the inflation reduction act
topic cardiovascular diseases
drug costs
Medicaid
Medicare Part D
prescription drugs
url https://www.ahajournals.org/doi/10.1161/JAHA.124.034682
work_keys_str_mv AT mohammedessa tenyearmedicareuseandspendingonthe10drugsselectedfornegotiationundertheinflationreductionact
AT josephsross tenyearmedicareuseandspendingonthe10drugsselectedfornegotiationundertheinflationreductionact
AT sanketsdhruva tenyearmedicareuseandspendingonthe10drugsselectedfornegotiationundertheinflationreductionact
AT niharrdesai tenyearmedicareuseandspendingonthe10drugsselectedfornegotiationundertheinflationreductionact
AT ericasspatz tenyearmedicareuseandspendingonthe10drugsselectedfornegotiationundertheinflationreductionact
AT kamilffaridi tenyearmedicareuseandspendingonthe10drugsselectedfornegotiationundertheinflationreductionact